152 Chapter 5 Table 3. Treatment effects on primary and key secondary outcomes from per-protocol analyses comparing compliance groups to TAU from baseline to 18-month follow-up (N = 102). TAU+FNC groups Outcome variables (measurement type) No compliance Low compliance High compliance Primary outcome Mental wellbeing (self-report)a -0.201 (-0.545 to 0.142) -0.341 (-0.685 to 0.003) -0.070 (-0.392 to 0.253) Key secondary outcomes Psychiatric functioning General psychiatric functioning (observer-rated)a -0.092 (-0.269 to 0.085) 0.137 (-0.048 to 0.321) -0.054 (-0.227 to 0.119) Hospitalization Number in addiction and psychiatric care (self-report)b 1.277 (0.573 to 2.848) 1.184 (0.513 to 2.728) 0.425 (0.090 to 2.001) Number in internal mental healthcare institute at 12 months (medical record)b 1.381 (0.340 to 5.604) 0.452 (0.044 to 4.660) 0.938 (0.154 to 5.703) Number in internal mental healthcare institute at 18 months (medical record)b 1.254 (0.358 to 4.392) 1.428 (0.319 to 6.385) 0.513 (0.093 to 2.837) Days in internal mental healthcare institute at 12 months (medical record)b 0.481 (0.239 to 0.970)* 1.212 (0.351 to 4.183) 0.293 (0.099 to 0.866)* Days in internal mental healthcare institute at 18 months (medical record)b 0.261 (0.130 to 0.524)*** 1.192 (0.331 to 4.293) 0.081 (0.029 to 0.229)*** Criminal recidivism Criminal behavior (self-report)b 0.206 (0.067 to 0.628)** 0.629 (0.227 to 1.740) 0.237 (0.060 to 0.933)* Incarceration (self-report)b 0.923 (0.319 to 2.669) 0.262 (0.063 to 1.091) 0.133 (0.017 to 1.033) Data were analyzed with LMM/GEE/GLM and presented as adjusted mean differences (95% CI) for continuous outcomes a and rate ratios (95% CI) for count outcomes b. TAU = reference category. * p<0.05 ** p<0.01 *** p<0.001
RkJQdWJsaXNoZXIy MjY0ODMw